About this trial
This Randomized Controlled Trial (RCT) aims to assess the effectiveness and acceptability of the Unified Protocol (UP) in an online group format for the treatment of emotional disorders in adults. Participants will be 90 adults (45 in the control group and 45 in the experimental group) with diagnosis of long COVID and comorbid emotional disorders. Participants will be recruited at Hospital Royo Villanova from Zaragoza, Spain.
In this study it will be explored whether the changes obtained after the intervention in emotional disorders and cognitive complaints are maintained over 12 months. Additionally, levels of chronic stress will be longitudinally evaluated in the experimental group through accumulated cortisol levels in hair, before and after the application of the UP.
Eligibility criteria
Qualifiers
Residing in Autonomous Community of Aragon (Spain).
Being at least 18 years old.
Understanding of Spanish.
Being diagnosed with long COVID-19: documented SARS-CoV-2 infection and persistence of symptoms beyond 12 weeks after the acute infection.
Disqualifiers
Pre-existing emotional symptoms prior to the acute SARS-CoV-2 infection.
Actually receiving psychological treatment.
Having a diagnosis of severe mental disorder (e.g., personality disorder, bipolar disorder, etc.).
Active suicidal ideation at the time of the assessment.
Trial design
Treatments tested in this trial
- Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders
- Treatment as Usual (TAU)
Treatment groups
Sponsors and collaborators
Instituto de Investigación Sanitaria Aragón
Lead sponsor
Universidad de Zaragoza
Sponsor institution
Hospital Royo Villanova de Zaragoza
Collaborator